Navigation Links
V. Suzanne Klimberg, M.D. Appointed Medical Director of Ascendant Diagnostics™
Date:9/24/2013

Fayetteville, Arkansas (PRWEB) September 24, 2013

Omid Moghadam, Chairman and CEO of Ascendant Diagnostics, recently named V. Suzanne Klimberg, M.D, to the position of Medical Director. Ascendant Diagnostics is in the process of developing the company’s first product, MelodyDx™, a pain-free, low-cost screening test that can detect the presence of early-stage breast cancer using the protein profile of a person’s tears.

With many distinguished achievements to her credit, Dr. Klimberg (in collaboration with Larry Suva, Ph.D.) discovered breast cancer protein patterns in tears and is the co-inventor of MelodyDx™. “Early detection of breast cancer is critical for saving lives, and we hope this technology will help us reach even more women for early screening,” says Dr. Klimberg. “While a mammogram is an essential screening tool, we know that many women are reluctant to get mammograms for a variety of reasons, and they’ll either delay getting a mammogram or avoid it altogether.”

Dr. Klimberg, a practicing breast surgeon, is the director of the Breast Cancer Program at the University of Arkansas for Medical Sciences (UAMS) Winthrop P. Rockefeller Cancer Institute in Little Rock, Ark. She holds the Muriel Balsam Kohn Chair in Breast Surgical Oncology and is a professor of surgery and pathology at UAMS. Since 1993, Dr. Klimberg has been director of Fellowship in Diseases of the Breast at the UAMS Cancer Institute and John L. McClellan VA Hospital.

Research has been an important component of Dr. Klimberg’s career and she has consistently received highly sought after and competitive funding awards from national organizations including: National Institutes of Health, American Cancer Society and Susan G. Komen Foundation. She holds a number of elected offices and appointments including President, Society of Surgical Oncology, Board Member, American Cancer Society and Board Member, American Society of Breast Surgeons. Dr. Klimberg has received numerous awards and honors, has produced more than 200 publications and chapters and serves on editorial boards for several professional journals.

“Dr. Klimberg will be leading clinical validation studies as well as educating health care providers about MelodyDx,” explains Moghadam. “Dr. Klimberg has made significant contributions to improving outcomes for women with breast cancer and we feel fortunate to have her helping us bring our diagnostic test to market.”

Ascendant Diagnostics’ vision is to greatly increase the accuracy of diagnostics of diseases, enable detection of disease at the earliest possible stage, and improve patient compliance through the use of non-invasive, pain-free diagnostic tools. The company's first product, MelodyDx™, is a patent pending, non-invasive, biomarker panel for the detection of breast cancer, which detects differences in proteins present in human tears. The goal for MelodyDx™ is to increase breast cancer detection at earlier stages while at the same time reducing unnecessary exposure to radiation and painful biopsy procedures. Ascendant Diagnostics, LLC is a VIC Technology Venture Development™ portfolio company.

Read the full story at http://www.prweb.com/releases/2013/9/prweb11155176.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Dr. Jeff Jonas Appointed President of Shire Regenerative Medicine Business and Joins Shire Leadership Team
2. Dr. Gil Ben-Menachem appointed Chief Executive Officer of OphthaliX Inc.
3. Infotrieve Appointed to EContent 100
4. Janet Kreizman Appointed Chief Executive Officer of AACC
5. Gregory Raupp Appointed Director of MacroTechnology Works at Arizona State University to Advance Flexible Electronics and Manufacturing
6. University of Maryland Breast Cancer Research Pioneer Dr. Angela Brodie Appointed Fellow of New American Association for Cancer Research Academy
7. ClearPath Workforce Management CEO Appointed Co-chair of Northern California Leadership Forum for Woman Owned Business Alliance
8. Ondine Biomedical CEO Carolyn Cross Appointed Treasurer of International Photodynamic Association
9. Quorum Review IRB Board Chair Appointed to SACHRP
10. James Mazzo Appointed Executive Chairman of Neurotech Pharmaceuticals
11. Roche NimbleGen and BGI Develop Advanced MHC Region Capture Technology for Human Disease and Biomedical Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... CA (PRWEB) , ... June 27, 2016 , ... ... for clinical trials, announced today the Clinical Reach Virtual Patient Encounter CONSULT ... care circle with the physician and clinical trial team. , Using the CONSULT module, ...
(Date:6/24/2016)... , June 24, 2016  Regular discussions on a ... take place between the two entities said Poloz. ... Ottawa , he pointed to the country,s ... the federal government. ... said, "Both institutions have common economic goals, why not sit ...
(Date:6/23/2016)... , ... June 23, 2016 , ... ... pleased to announce the launch of their brand, UP4™ Probiotics, into Target stores ... 35 years, is proud to add Target to its list of well-respected retailers. ...
(Date:6/23/2016)... ... June 23, 2016 , ... Charm Sciences, Inc. is ... has received AOAC Research Institute approval 061601. , “This is another AOAC-RI approval ... Bob Salter, Vice President of Regulatory and Industrial Affairs. “The Peel Plate methods ...
Breaking Biology Technology:
(Date:6/1/2016)... 2016 Favorable Government Initiatives Coupled ... Criminal Identification to Boost Global Biometrics System Market Through ... Research report, " Global Biometrics Market By Type, ... Opportunities, 2011 - 2021", the global biometrics market is ... account of growing security concerns across various end use ...
(Date:5/12/2016)... -- WearablesResearch.com , a brand of Troubadour Research ... the Q1 wave of its quarterly wearables survey. A ... to a program where they would receive discounts for ... "We were surprised to see that so ... , CEO of Troubadour Research, "primarily because there are ...
(Date:4/28/2016)... First quarter 2016:   , ... the first quarter of 2015 The gross margin was ... 18.8) and the operating margin was 40% (-13) Earnings ... flow from operations was SEK 249.9 M (21.2) , ... SEK 7,000-8,500 M. The operating margin for 2016 is ...
Breaking Biology News(10 mins):